Taiwan FDA registration 5297ae02ba2b3d18d6d08ea72ef602fc
"Taifu" Soladine syphilis test reagent
TW: "台富" 速樂定梅毒檢驗試劑
Taiwan·Risk Class 2·Taiwan Fu Pharmaceutical Co., Ltd·Registered Jan 20, 2006 – Jan 20, 2026CancelledRegistration details
- Analysis ID
- 5297ae02ba2b3d18d6d08ea72ef602fc
- Customs Code
- DHY00500197502
Company information
- Manufacturer
- Taiwan Fu Pharmaceutical Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Taiwan Fu Pharmaceutical Co., Ltd
Product details
- Intended Use
- Passive particle agglutination method was used to detect Treponema pallidum antibodies and antibody valence in human serum or plasma.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3830 Treponema pallidum test
- Import Information
- Domestic
Dates and status
- Registration Date
- Jan 20, 2006
- Expiry Date
- Jan 20, 2026
- Cancellation Date
- Oct 28, 2022
Cancellation information
- Status
- Logged out
- Reason
- 公司歇業
About this record
Access comprehensive regulatory information for "Taifu" Soladine syphilis test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5297ae02ba2b3d18d6d08ea72ef602fc and manufactured by Taiwan Fu Pharmaceutical Co., Ltd. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices